Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024

Bispecific antibodies (BsAbs) are cutting-edge immunotherapy agents that can bind two distinct antigens or epitopes simultaneously. They hold significant potential in targeting leukemic cell markers and activating immune cells like T cells or NK cells to eliminate malignant cells. BsAb treatments sh...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Weijie Cao, Shuhan Ma, Lijie Han, Hanzhou Xing, Yingmei Li, Zhongxing Jiang, Xuejun Guo, Jifeng Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Subjects:	bispecific antibodies acute lymphoblastic leukemia acute myeloid leukemia myelodysplastic syndrome (MDS) immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1566202/full